Financial Data and Key Metrics Changes - For the first fiscal quarter, the company reported revenue of $15.4 million, down from $18.3 million in the same period last year [52] - The company experienced a slight net loss of $73,000 or $0.02 per diluted share, compared to a net income of $1 million or $0.21 per diluted share in the prior year [42] - Gross revenue was $4.1 million or 26.6% of revenue, compared to $5.8 million or 31.7% of revenue in the same prior year period, with a decrease attributed to a mix of business and lower margin products [35] Business Line Data and Key Metrics Changes - The Technology Solutions (TS) business accounted for $14.7 million of overall revenue, driven by increased customer use of implementation, installation, and training capabilities [26] - The UCaaS business showed an increase in clients, indicating a profitable trend moving forward [27] - The high-performance products (HPP) business, particularly the AZT offering, is generating significant interest and is expected to grow substantially [30] Market Data and Key Metrics Changes - The company secured a multimillion-dollar contract with a global pharmaceutical company, deploying AZT across over 40 facilities [21] - A five-year multimillion-dollar contract was also announced for managed services with a prominent Florida public college [24] - The sales funnel for AZT is expanding, attracting prospects across the Fortune 500 [31] Company Strategy and Development Direction - The company is focusing on the AZT offering as a key growth driver, with expectations of significant market potential in cybersecurity solutions [30] - The Board of Directors raised the quarterly dividend to $0.05 per share, reflecting confidence in future growth [25] - The company is actively engaging with resellers to enhance product adoption and market presence [39] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the company's positioning for greater success throughout fiscal 2024, highlighting the growth of both the TS and HPP businesses [34] - The management acknowledged the challenging business environment but emphasized the team's ability to remain engaged with customers [28] - There is a strong belief that the increasing cybersecurity threats will drive demand for the AZT product [156] Other Important Information - The company is planning to attend several industry conferences to increase visibility and market engagement [50] - Management noted that the cruise-related business is beginning to see positive developments after a quiet period during the pandemic [28] - The company is in discussions with multiple potential buyers for the AZT product, with some progressing towards contracts [119] Q&A Session Summary Question: How will the new pharmaceutical contract impact the income statement? - The revenue from the contract will be recognized all at once in the upcoming quarter [45] Question: Is there any progress in the cruise ship business? - There has been progress with new technology being rolled out to several ships, providing a new income stream [45] Question: Can the company disclose the name of the pharmaceutical customer? - The company needs to obtain permission from the customer before disclosing their name [47][48] Question: What is the pricing model for the AZT product? - The AZT product will generally follow a monthly recurring revenue model, with some exceptions for upfront payments [99] Question: Are there plans to provide revenue guidance in the future? - There are plans to consider providing guidance, but it is not currently available [141] Question: Why would large enterprises choose the AZT product over developing their own? - The crowded security space and the unique capabilities of the AZT product fill specific needs that existing solutions do not address [167]

Table of Contents United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2023 or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0-10843 CSP Inc. (Exact name of Registrant as specified in its charter) Massachusetts 04-2441294 (State or other jurisdi ...

Financial Data and Key Metrics Changes - The company reported a revenue growth of 19% for fiscal 2023 compared to fiscal 2022, achieving a total revenue of $54.4 million [13][21] - For Q4, revenue was $15.3 million, down from $16.7 million in the previous year, with a significant revenue increase of 66% in last year's Q4 due to backlog reduction [20][21] - Gross profit for the fiscal year was $21.9 million, representing 34% of sales, compared to $18.8 million or 35% of sales in fiscal 2022, indicating a slight decrease in gross margin [21][22] - Net income for the fiscal year was $5.2 million or $1.09 per diluted share, compared to $1.9 million or $0.42 per diluted share in the previous year [22][61] Business Line Data and Key Metrics Changes - The Technology Solutions (TS) business continued to perform well, contributing significantly to revenue growth, with a focus on implementation, installation, and training capabilities [15][38] - The High-Performance Products (HPP) business recorded total revenue of $6.9 million for the fiscal year, up from $3.8 million in fiscal 2022, driven by the launch of the AZT PROTECT solution [34][38] Market Data and Key Metrics Changes - The company noted a reduction in backlog to approximately $7.6 million, returning to pre-pandemic levels, which is expected to facilitate normal business operations moving forward [33][43] - The company is actively engaging with Fortune 500 companies and has received orders from significant clients, including a chemical manufacturing company and a Western Intelligence Agency [37][38] Company Strategy and Development Direction - The company aims to transition to higher-margin products and services, with a focus on the AZT cybersecurity solution, which is expected to drive future growth [32][38] - The management emphasized the importance of marketing and sales efforts to enhance brand recognition and market penetration, particularly in the cybersecurity space [134][135] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing positive momentum in the TS and HPP businesses and the successful conversion of backlog to revenue [13][32] - The company is addressing supply chain challenges and is confident in its ability to grow despite a reduction in backlog [33][43] Other Important Information - The Board of Directors approved a quarterly dividend of $0.04 per share, payable on January 9, 2024 [23] - The company has significantly increased its marketing budget and hired industry-leading salespeople to enhance its market presence [134][135] Q&A Session Summary Question: What is the expected growth for the Technology Solutions business in 2024? - Management confirmed that they budgeted for significant growth in 2024 despite the drop in backlog, indicating confidence in business operations [25][44] Question: How is the AZT product expected to contribute to future growth? - Management highlighted that the AZT product is dynamic and has the potential to significantly impact future business, with ongoing efforts to grow the sales pipeline [46][47] Question: What is the market opportunity for AZT? - Management indicated that the market opportunity for AZT is multibillion, reflecting strong potential for growth [78] Question: How does the company plan to enhance shareholder value? - Management acknowledged the need for improved communication with the market and plans to enhance marketing efforts to better convey the company's opportunities [132][135] Question: Will the company consider a stock split in the future? - Management confirmed that they have discussed the possibility of a stock split at the Board level [154]

[Part I](index=4&type=section&id=PART%20I) [Business](index=4&type=section&id=Item%201.%20Business) CSP Inc. operates through Technology Solutions (TS) for IT integration and High Performance Products (HPP) for cybersecurity and network solutions, with TS accounting for 89% of fiscal 2023 sales - The company operates in two primary segments: Technology Solutions (TS), which provides IT integration and managed services, and High Performance Products (HPP), which develops and sells cybersecurity and network products[4](index=4&type=chunk) Sales by Operating Segment (Fiscal Years 2023 vs. 2022) | Segment | 2023 Sales (in thousands) | 2023 % of Total | 2022 Sales (in thousands) | 2022 % of Total | | :--- | :--- | :--- | :--- | :--- | | TS | $57,774 | 89% | $50,518 | 93% | | HPP | $6,873 | 11% | $3,843 | 7% | | **Total Sales** | **$64,647** | **100%** | **$54,361** | **100%** | - The TS segment's backlog decreased significantly from **$18.2 million** in FY2022 to **$7.5 million** in FY2023, attributed to the easing of prior-year supply chain issues[41](index=41&type=chunk) - The HPP segment's backlog also decreased from **$5.0 million** in FY2022 to **$1.8 million** in FY2023, with fluctuations driven by the timing of large government-related orders[439](index=439&type=chunk) - As of September 30, 2023, the company had approximately **112 full-time equivalent employees** worldwide, none of whom are represented by a labor union[355](index=355&type=chunk) [Risk Factors](index=15&type=section&id=Item%201A.%20Risk%20Factors) The company faces key risks including customer and government contract dependence, sole-source supplier reliance, intense competition, and intellectual property protection challenges - The company is reliant on a small number of significant customers; in fiscal 2022, one customer accounted for **19% ($10.4 million)** of total revenues, though no single customer reached the 10% threshold in fiscal 2023[25](index=25&type=chunk) - The HPP segment depends on sole-source suppliers like NVIDIA for critical components, where any disruption could materially adversely affect business operations[28](index=28&type=chunk) - A portion of revenue comes from contracts with the U.S. federal government, primarily the Department of Defense (DoD), accounting for **5% of total revenue** as a subcontractor in FY2023, making changes in government budgetary priorities a significant risk[56](index=56&type=chunk)[449](index=449&type=chunk) - The company has made significant investments in its ARIA SDS cybersecurity products, and their commercial success is not guaranteed, with failure to achieve expected returns potentially unfavorably affecting revenue and profitability[26](index=26&type=chunk) - The company's stock price is subject to volatility due to factors such as loss of major customers or suppliers, variations in quarterly results, and broader market fluctuations[88](index=88&type=chunk)[89](index=89&type=chunk) [Properties](index=30&type=section&id=Item%202.%20Properties) As of September 30, 2023, the company's principal facilities, including its corporate headquarters and manufacturing site, are all leased Principal Leased Facilities | Location | Principal Use | Approximate Floor Area | | :--- | :--- | :--- | | Lowell, MA | Corporate HQ, Manufacturing, Sales, Admin | 8,257 S.F. | | Center Drive, 33442 | Division HQ, Sales, Marketing, Admin | 11,815 S.F. | | Mulberry Business Park, UK | Sales, Marketing, Admin | 484 S.F. | [Legal Proceedings](index=30&type=section&id=Item%203.%20Legal%20Proceedings) The company reports that it is not currently a party to any material legal proceedings - As of the report date, the company is not involved in any material legal proceedings[91](index=91&type=chunk) [Mine Safety Disclosures](index=30&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company's operations - Not Applicable[92](index=92&type=chunk) [Part II](index=30&type=section&id=PART%20II) [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=30&type=section&id=Item%205.%20Market%20for%20Registrant's%20Common%20Equity%2C%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) The company's common stock trades on Nasdaq under CSPI, with quarterly cash dividends paid in fiscal 2023 and approximately 1,891 beneficial owners as of December 6, 2023 Quarterly Common Stock Price Range (Nasdaq) | Fiscal Quarter | 2023 High | 2023 Low | 2022 High | 2022 Low | | :--- | :--- | :--- | :--- | :--- | | 1st Quarter | $9.45 | $7.01 | $9.30 | $8.09 | | 2nd Quarter | $13.59 | $9.43 | $8.94 | $6.99 | | 3rd Quarter | $14.80 | $10.50 | $9.68 | $6.81 | | 4th Quarter | $23.59 | $10.15 | $8.95 | $7.12 | Cash Dividends Paid Per Share | Fiscal Year | Payment Date | Amount Per Share | | :--- | :--- | :--- | | 2022 | 9/9/2022 | $0.03 | | 2023 | 1/6/2023 | $0.03 | | 2023 | 3/14/2023 | $0.03 | | 2023 | 6/13/2023 | $0.04 | | 2023 | 9/12/2023 | $0.04 | - As of December 6, 2023, the company had approximately **63 holders of record** and an estimated **1,891 beneficial owners** of its common stock[94](index=94&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=31&type=section&id=Item%207.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) In fiscal 2023, revenue increased 19% to **$64.6 million**, operating income improved to **$1.8 million**, and net income rose significantly to **$5.2 million**, supported by an Employee Retention Tax Credit and a tax benefit from valuation allowance release [Results of Operations](index=31&type=section&id=Results%20of%20Operations) Fiscal 2023 revenue grew by **$10.2 million (19%)** year-over-year, driven by increased TS segment revenue and two major non-recurring HPP transactions, while overall gross margin slightly decreased Fiscal Year 2023 vs. 2022 Financial Highlights (in thousands) | Metric | FY 2023 | FY 2022 | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | **Total Revenue** | **$64,647** | **$54,361** | **$10,286** | **19%** | | Gross Profit | $21,920 | $18,827 | $3,093 | 16% | | Operating Income (Loss) | $1,870 | $(40) | $1,910 | N/A | | Net Income | $5,204 | $1,889 | $3,315 | 175% | - TS segment revenue increased by **14% ($7.3 million)**, driven by increased customer budgets as the economic environment returned to pre-pandemic levels and a significant decrease in order backlog due to fewer supply chain delays[120](index=120&type=chunk) - HPP segment revenue increased by **79% ($3.0 million)**, primarily due to two major non-recurring transactions totaling **$3.0 million** in fiscal 2023[102](index=102&type=chunk) - Other income increased to **$2.9 million** from **$2.0 million**, largely due to the recognition of a **$2.1 million** Employee Retention Tax Credit, net of costs[98](index=98&type=chunk)[153](index=153&type=chunk) - The company recorded an income tax benefit of **$469 thousand** in FY2023, compared to a **$50 thousand** provision in FY2022, primarily driven by a **$1.8 million** benefit from the release of a valuation allowance against deferred tax assets[79](index=79&type=chunk)[154](index=154&type=chunk) [Liquidity and Capital Resources](index=38&type=section&id=Liquidity%20and%20Capital%20Resources) The company's liquidity remains strong, with cash and cash equivalents increasing to **$25.2 million** at fiscal year-end 2023, supported by **$3.9 million** in cash from operations - Cash and cash equivalents increased by **$1.2 million**, from **$24.0 million** at FYE 2022 to **$25.2 million** at FYE 2023[115](index=115&type=chunk) Summary of Cash Flows (in thousands) | Activity | FY 2023 | FY 2022 | | :--- | :--- | :--- | | Net cash provided by Operating activities | $3,907 | $2,675 | | Net cash (used in) provided by Investing activities | $(341) | $20 | | Net cash (used in) provided by Financing activities | $(2,401) | $1,328 | - The company maintains a **$15.0 million** line of credit for inventory, with **$13.5 million** available as of September 30, 2023[159](index=159&type=chunk) - Dividends paid increased to **$0.7 million** in FY2023 from **$0.1 million** in FY2022, following a dividend increase to **$0.04 per share** in Q3 2023[158](index=158&type=chunk) [Critical Accounting Estimates and Policies](index=42&type=section&id=Critical%20Accounting%20Estimates%20and%20Policies) The company's critical accounting policies involve significant judgments and estimates in revenue recognition, valuation allowances for doubtful accounts and deferred tax assets, inventory valuation, and pension obligations - Significant judgment is required for revenue recognition, especially in allocating transaction prices for contracts with multiple components and determining whether to recognize third-party service revenue on a gross or net basis[164](index=164&type=chunk)[146](index=146&type=chunk)[148](index=148&type=chunk) - The company must make estimates regarding the valuation of deferred tax assets, which led to the reversal of a **$1.8 million** valuation allowance in FY2023 based on improved performance and future outlook[169](index=169&type=chunk)[155](index=155&type=chunk) - Estimates for pension plan obligations rely on actuarial assumptions, including discount rates and expected long-term rates of return on plan assets, which can significantly impact pension expense[196](index=196&type=chunk) - Inventory is valued at the lower of cost or market, requiring management to estimate future demand and market conditions to assess potential obsolescence and apply write-downs[194](index=194&type=chunk) [Financial Statements and Supplementary Data](index=48&type=section&id=Item%208.%20Financial%20Statements%20and%20Supplementary%20Data) This section contains the company's audited consolidated financial statements for fiscal years ended September 30, 2023, and 2022, including the Report of Independent Registered Public Accounting Firm and various financial statements - This item includes the full set of consolidated financial statements and the report from the independent registered public accounting firm, RSM US LLP[174](index=174&type=chunk) [Changes in and Disagreements with Accountants on Accounting and Financial Disclosures](index=49&type=section&id=Item%209.%20Changes%20in%20and%20Disagreements%20with%20Accountants%20on%20Accounting%20and%20Financial%20Disclosures) The company reports no changes in or disagreements with its accountants on accounting and financial disclosures - There were no disagreements with accountants on any matter of accounting principles or practices, or financial statement disclosure[175](index=175&type=chunk)[200](index=200&type=chunk) [Controls and Procedures](index=49&type=section&id=Item%209A.%20Controls%20and%20Procedures) The CEO and CFO concluded that disclosure controls and procedures were effective as of September 30, 2023, and management assessed internal control over financial reporting as effective with no material changes during the fiscal year - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of September 30, 2023[176](index=176&type=chunk) - Management's assessment, based on the COSO 2013 framework, concluded that the company's internal control over financial reporting was effective as of September 30, 2023[202](index=202&type=chunk) - No changes in internal control over financial reporting occurred during fiscal year 2023 that have materially affected, or are reasonably likely to materially affect, these controls[205](index=205&type=chunk) [Other Information](index=51&type=section&id=Item%209B.%20Other%20Information) The company reports that no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement during the fourth quarter of fiscal 2023 - No director or officer adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement in the three months ended September 30, 2023[206](index=206&type=chunk) [Part III](index=51&type=section&id=PART%20III) [Directors, Executive Officers and Corporate Governance](index=51&type=section&id=Item%2010.%20Directors%2C%20Executive%20Officers%20and%20Corporate%20Governance) Information regarding directors, executive officers, and corporate governance is incorporated by reference from the company's definitive proxy statement for its 2024 Annual Meeting of Stockholders - Information is incorporated by reference from the company's Schedule 14A Proxy Statement for the 2024 Annual Meeting of Stockholders[182](index=182&type=chunk) [Executive Compensation](index=51&type=section&id=Item%2011.%20Executive%20Compensation) Information concerning the compensation of executive officers and non-employee directors is incorporated by reference from the company's definitive proxy statement for its 2024 Annual Meeting of Stockholders - Information is incorporated by reference from the company's Schedule 14A Proxy Statement for the 2024 Annual Meeting of Stockholders[183](index=183&type=chunk) [Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](index=51&type=section&id=Item%2012.%20Security%20Ownership%20of%20Certain%20Beneficial%20Owners%20and%20Management%20and%20Related%20Stockholder%20Matters) This section provides information on securities authorized for issuance under equity compensation plans, with **295,076** securities to be issued upon exercise of outstanding rights and **514,939** remaining available for future issuance as of September 30, 2023 Equity Compensation Plan Information (as of Sept 30, 2023) | Plan Category | Securities to be issued upon exercise of outstanding options, warrants and rights | Weighted-average exercise price | Securities remaining available for future issuance | | :--- | :--- | :--- | :--- | | Equity plans approved by security holders | 295,076 | $ — | 514,939 | - Additional information regarding security ownership is incorporated by reference from the company's Schedule 14A Proxy Statement[234](index=234&type=chunk) [Certain Relationships and Related Transactions, and Director Independence](index=52&type=section&id=Item%2013.%20Certain%20Relationships%20and%20Related%20Transactions%2C%20and%20Director%20Independence) Information regarding related party transactions and director independence is incorporated by reference from the company's definitive proxy statement for its 2024 Annual Meeting of Stockholders - Information is incorporated by reference from the company's Schedule 14A Proxy Statement for the 2024 Annual Meeting of Stockholders[210](index=210&type=chunk)[235](index=235&type=chunk) [Principal Accountant Fees and Services](index=52&type=section&id=Item%2014.%20Principal%20Accountant%20Fees%20and%20Services) Information concerning fees for professional services provided by the principal accountant and pre-approval policies is incorporated by reference from the company's definitive proxy statement for its 2024 Annual Meeting of Stockholders - Information is incorporated by reference from the company's Schedule 14A Proxy Statement for the 2024 Annual Meeting of Stockholders[187](index=187&type=chunk)[211](index=211&type=chunk) [Part IV](index=52&type=section&id=PART%20IV) [Exhibits and Financial Statement Schedules](index=52&type=section&id=Item%2015.%20Exhibits%20and%20Financial%20Statement%20Schedules) This section lists the financial statements, financial statement schedules, and exhibits filed as part of the Form 10-K report, with consolidated financial statements included within the report and a detailed list of exhibits provided - This item lists the financial statements filed as part of the report, including the Consolidated Balance Sheets, Statements of Operations, Comprehensive Income, Shareholders' Equity, and Cash Flows[188](index=188&type=chunk)[211](index=211&type=chunk)[212](index=212&type=chunk) - A list of all exhibits filed with the Form 10-K is provided, including governance documents, compensation plans, material agreements, and required certifications under the Sarbanes-Oxley Act[238](index=238&type=chunk) [Form 10-K Summary](index=56&type=section&id=Item%2016.%20Form%2010-K%20Summary) The company indicates that no Form 10-K summary is provided - None[216](index=216&type=chunk)

Financial Data and Key Metrics Changes - The company reported revenue of $17.7 million for the fiscal third quarter, a 33% increase compared to $13.3 million in the same period last year [21] - Net income for the fiscal third quarter was $2.5 million, or diluted earnings per share of $0.52, compared to net income of $684,000, or diluted earnings per share of $0.15, for the fiscal 2022 third quarter [50] - Gross profit was $5.9 million, representing 33.4% of sales, compared to $4.9 million or 37.4% of sales in the previous year [48] Business Line Data and Key Metrics Changes - The Technology Solutions (TS) business revenue totaled $16.4 million, up from $12.6 million in the previous year, driven by increased customer use of implementation, installation, and training capabilities [16] - High-Performance Product (HPP) revenue was approximately $1.3 million, compared to $700,000 in the year-ago fiscal third quarter [6] Market Data and Key Metrics Changes - The company is experiencing a growing customer base for its ARIA product line, with a high pipeline expected to positively impact revenue in upcoming quarters [6][7] - The company has entered into agreements in international markets, including Australia, indicating a focus on expanding its global presence [9] Company Strategy and Development Direction - The company aims to convert the remaining backlog to revenue while maintaining customer engagement regarding supply timelines [42] - The launch of the AZT PROTECT product is expected to be a significant growth driver for the HPP business moving into fiscal 2024 and beyond [43][46] - The company is ramping up sales and marketing investments to address various industries, including utilities, logistics, and healthcare [19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to fulfill customer orders despite supply chain challenges, noting that no orders have been lost during this period [42] - The management highlighted the positive early feedback on the AZT product and its potential to differentiate the company from larger competitors [44] Other Important Information - The company declared a quarterly dividend of $0.04 per share, payable on September 12, 2023 [25] - Cash and cash equivalents were reported at $13.8 million as of June 30, 2023, down from $23.9 million as of September 30, 2022 [50] Q&A Session Summary Question: Has there been any discussions with larger companies to market the AZT product faster? - Management stated that discussions are ongoing but emphasized the importance of building a customer base first [27] Question: Will the repayment of receivables bring cash over $20 million? - Management indicated that it would be close to that amount, with fluctuations based on payables [28][29] Question: What is the status of share repurchases? - A very small number of shares have been repurchased, and management is reviewing the situation with the Board [31][33] Question: Are there any updates on international sales? - Management confirmed ongoing discussions with potential international partners, particularly in Europe and the UK [59] Question: What is the expected sales cycle for the new AZT product? - Management noted that the sales cycle is still being determined but is optimistic about quicker adoption due to the product's necessity [136]

Our sales increased by approximately $11.6 million, or 31%, to $49.3 million for the nine months ended June 30, 2023 as compared to $37.7 million for the nine months ended June 30, 2022. The increase in sales is the result of an increase of $9.3 million in our TS segment and an increase of approximately $2.3 million in our HPP segment. HPP segment sales change was as follows for the nine months ended June 30, 2023 and 2022: 31 The $11.8 million increase in sales to the Americas was primarily the result of a ...

CSP Inc. (NASDAQ:CSPI) Q2 2023 Earnings Conference Call May 10, 2023 10:00 AM ET Company Participants Michael Polyviou - Investor Relations Victor Dellovo - Chief Executive Officer Gary Levine - Chief Financial Officer Conference Call Participants Joseph Nerges - Segren Investments Brett Davidson - Private Investor Operator Good morning, everybody and welcome to CSPI Second Quarter Fiscal Year 2023 Results Conference Call. [Operator Instructions] Please note this conference is being recorded. I will now tur ...

Table of Contents ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0-10843 | --- | --- | --- | --- | |--------------------------------------------------------------|------------------------------------------|---------------------|------------------------------------------ ...

CSP Inc. (NASDAQ:CSPI) Q1 2023 Earnings Conference Call February 8, 2023 10:00 AM ET Company Participants Michael Polyviou - IR Victor Dellovo - CEO Gary Levine - CFO Conference Call Participants Joseph Nerges - Sergen Investments Brett Davidson - Investletter Operator Good day, and welcome to the CSPi's First Quarter and Fiscal Year 2023 Conference Call. At this time, all participants have been placed on listen-only mode and the floor will be opened for questions and comments after the presentation. It is ...

Table of Contents United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2022 or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0-10843 CSP Inc. (Exact name of Registrant as specified in its charter) (Registrant's telephone number, including area c ...